Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

ENCORAT™ CHRONO prolonged-release tablets 300mg, 30pcs

🔥 7 items sold in last 3 hours
19 people are viewing this product
Active Ingredient:

Manufacturer:

$9.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

ENCORAT™ CHRONO prolonged-release tablets 500mg, 30pcs

$14.00
Add to cart

Analogs of ENCORAT™ CHRONO

VALPARIN™ XR prolonged-release tablets 300mg, 100pcs

$28.00
Add to cart

VALPARIN™ XR prolonged-release tablets 300mg, 30pcs

$10.00
Add to cart

VALPARIN™ XR prolonged-release tablets 500mg, 100pcs

$43.00
Add to cart

VALPARIN™ XR prolonged-release tablets 500mg, 30pcs

$15.00
Add to cart

Table of Contents

ENCORAT™ CHRONO 300mg Tablets Buy Online

Encorat Chrono: Understanding its Role in Epilepsy Management

Epilepsy, a neurological disorder marked by seizures, significantly impacts the lives of millions. Effective management requires careful consideration of treatment options, and Encorat Chrono plays a crucial role in this process. This prolonged-release formulation of valproic acid offers a convenient and potentially effective approach to controlling seizures.

Encorat Chrono provides a consistent release of medication over an extended period, minimizing fluctuations in blood levels. This consistent delivery can help to prevent breakthrough seizures and improve overall seizure control. The extended-release mechanism also contributes to improved patient compliance.

Understanding the nuances of Encorat Chrono’s mechanism of action and potential side effects is essential for both patients and healthcare professionals. This detailed look into Encorat Chrono will help clarify its role in comprehensive epilepsy management.

A Powerful Anticonvulsant

Encorat Chrono, containing valproic acid, is a cornerstone in the management of various epilepsy syndromes. Its efficacy stems from its robust anticonvulsant properties, effectively suppressing excessive neuronal activity responsible for seizures. This action helps prevent the onset of seizures, offering significant relief for those living with this debilitating condition.

Valproic acid’s mechanism is multifaceted, influencing several neurotransmitter systems crucial in seizure control. It’s believed to enhance the inhibitory effects of GABA (gamma-aminobutyric acid), a neurotransmitter that dampens neuronal excitability. Simultaneously, it modulates other ion channels, further contributing to its anticonvulsant action. This complex mechanism makes it effective against a wide spectrum of seizure types.

The prolonged-release formulation of Encorat Chrono is particularly advantageous. By providing a sustained release of valproic acid, it maintains therapeutic drug levels throughout the day, minimizing the risk of breakthrough seizures. This consistent delivery is vital for consistent seizure control and improved patient quality of life. The extended-release design contributes to better adherence to the prescribed treatment regimen.

Clinically, Encorat Chrono has shown effectiveness in managing both generalized and partial seizures, including absence, myoclonic, tonic-clonic, and atonic seizures. It is often used as a monotherapy or in combination with other antiepileptic drugs (AEDs) for optimal seizure management. The choice between monotherapy and combination therapy depends on the specific needs of the individual patient and the type and severity of seizures they are experiencing.

While generally safe and effective, it’s crucial to remember that individual responses to medication vary. Close monitoring and regular consultations with a neurologist are essential to adjust dosage and manage potential side effects. The careful consideration of individual patient factors and the close collaboration between patients and healthcare professionals are key to the successful use of Encorat Chrono in epilepsy management.

Mechanism of Action

Encorat Chrono’s effectiveness hinges on its active ingredient, valproic acid, a broad-spectrum anticonvulsant with a complex mechanism of action. It doesn’t target a single pathway but rather influences several neuronal processes contributing to seizure control. This multifaceted approach explains its efficacy across various epilepsy types.

One key mechanism involves the enhancement of GABAergic inhibition. GABA, a major inhibitory neurotransmitter, reduces neuronal excitability. Valproic acid boosts GABA’s effects, dampening the excessive neuronal firing that characterizes seizures. This increased inhibitory tone helps prevent the runaway electrical activity responsible for seizures.

Beyond GABA modulation, valproic acid also influences other ion channels crucial for neuronal excitability. It affects sodium and calcium channels, reducing their activity and thus limiting the influx of positively charged ions into neurons. This reduction in ion influx further contributes to the suppression of excessive neuronal firing.

Furthermore, valproic acid impacts the synthesis and metabolism of neurotransmitters, indirectly influencing neuronal activity. Its effects on neurotransmitter systems are complex and not fully understood but contribute to its overall anticonvulsant properties. This intricate interplay of mechanisms makes valproic acid a potent tool in managing a wide range of seizure disorders.

The prolonged-release formulation of Encorat Chrono is key to its effectiveness. This controlled release ensures consistent levels of valproic acid in the bloodstream, minimizing fluctuations and preventing the abrupt rises and falls in drug concentration that could trigger breakthrough seizures. The consistent therapeutic drug levels are critical for maintaining seizure control and improving the patient’s overall quality of life.

In summary, Encorat Chrono’s mechanism isn’t confined to a single action but instead involves a complex interplay of actions at multiple levels within the central nervous system. This multifaceted approach contributes to its broad efficacy in managing diverse epilepsy syndromes and makes it a valuable treatment option for many patients.

Treatment Applications

Encorat Chrono’s therapeutic applications are primarily focused on the management of epilepsy, a chronic neurological disorder affecting millions worldwide. Its efficacy extends to various epilepsy types, highlighting its versatility as a treatment option. The consistent release of valproic acid contributes to improved seizure control and a better quality of life for patients.

Encorat Chrono is particularly effective in treating a wide range of seizure types. This includes generalized seizures, such as tonic-clonic, absence, myoclonic, and atonic seizures. It’s also shown efficacy in managing partial seizures, which may or may not spread to involve the entire brain. The drug’s versatility in targeting diverse seizure types is a significant clinical advantage.

In many cases, Encorat Chrono is used as monotherapy, meaning it’s the sole antiepileptic drug prescribed. However, its effectiveness can be further enhanced when used in combination with other antiepileptic drugs (AEDs) for those whose seizures are not adequately controlled by a single medication. The decision to use Encorat Chrono as monotherapy or in combination therapy is based on individual patient needs and seizure response.

Beyond its primary use in epilepsy, valproic acid, the active component of Encorat Chrono, has shown potential in managing other neurological conditions. While not the primary indication for Encorat Chrono, research continues to explore its potential applications in managing certain types of migraine and bipolar disorder. Further research is needed to fully understand and define these potential applications outside of epilepsy.

It’s crucial to emphasize that Encorat Chrono should only be used under the strict supervision of a healthcare professional experienced in managing epilepsy. Dosage adjustments are often necessary to optimize treatment effectiveness and manage potential side effects. Individualized treatment plans are essential for achieving the best possible outcomes for each patient.

The decision to use Encorat Chrono, its dosage, and any combination therapies should always be determined by a neurologist or other qualified healthcare provider. They will consider the patient’s specific seizure type, severity, and overall health to create a personalized treatment plan that maximizes benefits and minimizes potential risks. Regular monitoring of treatment efficacy and side effects is also crucial.

Dosage and Administration

The administration and dosage of Encorat Chrono are crucial for achieving optimal therapeutic effects while minimizing potential adverse reactions. Dosage is strictly individualized, tailored to the patient’s specific needs, weight, and response to treatment. A healthcare professional experienced in epilepsy management must determine the appropriate dosage and monitor its effectiveness.

Typically, treatment begins with a low dose, gradually increased over time until the desired therapeutic effect is achieved. This titration process allows for close monitoring of the patient’s response and minimizes the risk of side effects. The goal is to find the lowest effective dose that adequately controls seizures.

Encorat Chrono tablets are designed for oral administration. They should be swallowed whole with a meal to enhance absorption and minimize gastrointestinal upset. The tablets should not be crushed, broken, or chewed, as this would compromise the controlled-release mechanism. This sustained release is vital for maintaining consistent levels of valproic acid throughout the day.

Regular monitoring of blood levels of valproic acid may be necessary to ensure that the dosage is appropriate and therapeutic. This monitoring helps fine-tune the dosage to achieve optimal seizure control while minimizing side effects. Blood tests allow healthcare professionals to make informed decisions about dosage adjustments.

It’s critical to understand that the information provided here is for general knowledge only and should not be interpreted as medical advice. Individual dosage regimens should always be determined and closely monitored by a qualified healthcare professional. Self-adjusting medication dosages can be dangerous and should be avoided.

Patients should always adhere strictly to the prescribed dosage and administration instructions. Missing doses or altering the prescribed regimen can significantly impact treatment efficacy and increase the risk of breakthrough seizures. Consistent adherence is key to long-term seizure control and improved quality of life. Open communication with the healthcare provider is vital for managing the treatment and addressing any concerns.

Potential Side Effects

While Encorat Chrono offers significant benefits in managing epilepsy, it’s crucial to be aware of potential side effects. These side effects vary in severity and frequency, with some being mild and transient while others may require medical attention. Close monitoring by a healthcare professional is essential to manage any adverse reactions.

Gastrointestinal issues are among the most commonly reported side effects. These can include nausea, vomiting, diarrhea, and constipation. These effects are often mild and may resolve spontaneously as the body adjusts to the medication. Dietary modifications and over-the-counter remedies may help alleviate these symptoms, but medical advice should be sought if symptoms persist or worsen.

Weight changes, either weight gain or weight loss, can also occur. Changes in appetite often accompany these weight fluctuations. Maintaining a healthy diet and regular exercise can help mitigate these effects, but monitoring weight is important, especially in children and adolescents. A healthcare professional should be informed of significant weight changes.

More serious, though less common, side effects include hepatotoxicity (liver damage) and pancreatitis (inflammation of the pancreas). Regular liver function tests are often recommended, particularly during the initial stages of treatment, to detect any abnormalities early. Immediate medical attention is crucial if symptoms such as jaundice, abdominal pain, or unusual fatigue develop.

Other potential side effects can include tremor, hair loss, and thrombocytopenia (low platelet count). The incidence and severity of these side effects vary greatly among individuals. Regular monitoring, including blood tests, is essential to detect and manage these complications. The healthcare professional should be notified of any unusual symptoms or concerns.

It’s vital to remember that this list doesn’t encompass all possible side effects. Patients should consult the medication’s complete prescribing information and promptly report any new or worsening symptoms to their healthcare provider. Open communication and regular monitoring are critical for safe and effective treatment with Encorat Chrono.

Pros

Encorat Chrono offers several key advantages in the management of epilepsy, making it a valuable treatment option for many patients. Its efficacy in controlling various seizure types, coupled with its convenient administration, contributes significantly to improved patient outcomes and quality of life. The prolonged-release formulation addresses many challenges associated with traditional anticonvulsant therapies.

One significant advantage is the sustained release of valproic acid. This provides consistent therapeutic drug levels throughout the day, reducing the risk of breakthrough seizures. This consistent delivery is crucial for maintaining seizure control and improving patient compliance, as fewer doses are needed compared to immediate-release formulations.

The convenience of once-daily dosing simplifies the treatment regimen, enhancing adherence. This is especially beneficial for patients who may struggle with remembering multiple daily doses. Improved adherence to the prescribed medication is linked to better seizure control and overall treatment success.

Encorat Chrono’s effectiveness across a broad spectrum of seizure types is another key advantage. Its efficacy in managing both generalized and partial seizures makes it a versatile treatment option suitable for many patients. This versatility reduces the need for multiple medications, simplifying treatment and potentially reducing the risk of drug interactions.

Finally, the prolonged-release formulation potentially minimizes gastrointestinal side effects compared to immediate-release formulations. This is because the slower release reduces the initial peak concentration of the drug in the stomach, lessening the likelihood of nausea and vomiting. Improved gastrointestinal tolerability enhances patient comfort and adherence to the treatment regimen.

It’s important to note that while these are significant advantages, individual responses to Encorat Chrono can vary. The effectiveness and tolerability of the medication should be assessed on a case-by-case basis under the guidance of a healthcare professional. Careful monitoring is essential to ensure that the treatment is both effective and well-tolerated.

Cons

While Encorat Chrono offers significant benefits, it’s essential to acknowledge potential drawbacks. Understanding these potential downsides allows for informed decision-making in consultation with a healthcare professional. Individual responses to medication vary, and what may be a minor inconvenience for one patient could be a significant issue for another.

A major consideration is the risk of serious side effects, although relatively uncommon. These include hepatotoxicity (liver damage) and pancreatitis (inflammation of the pancreas). Regular monitoring of liver function is crucial, especially during the initial phase of treatment. Immediate medical attention is necessary if symptoms suggestive of liver or pancreatic problems arise.

Gastrointestinal disturbances, while often mild, can significantly impact a patient’s quality of life. Nausea, vomiting, diarrhea, and constipation are frequently reported side effects. These symptoms can be managed with dietary modifications and sometimes with medication, but they can still be disruptive to daily routines.

Weight changes, both gain and loss, are also possible. These fluctuations can be distressing for some patients and may require additional management strategies, including dietary adjustments and lifestyle modifications. Weight changes can also be an indicator of other underlying issues, necessitating further investigation.

Furthermore, Encorat Chrono, like many medications, can interact with other drugs. This necessitates careful consideration of a patient’s entire medication regimen to minimize the potential for adverse interactions. It’s crucial to inform all healthcare providers of all medications, supplements, and herbal remedies being taken to prevent potentially dangerous drug interactions.

Finally, individual responses to medication can vary. What is well-tolerated by one patient may cause significant side effects in another. Close monitoring and open communication with a healthcare provider are essential to manage any adverse reactions and optimize treatment outcomes. The potential benefits must always be weighed against the potential risks on a case-by-case basis.

  • Encorat™ Chrono Prolonged-Release Tablets 300Mg, 30Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Encorat™ Chrono Prolonged-Release Tablets 300Mg, 30Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Encorat™ Chrono Prolonged-Release Tablets 300Mg, 30Pcs Buy Online 6
    [Medical reviewer]

    Dr. Lewis Rappaport is a highly experienced and respected cardiologist who serves as a salaried specialist and consultant for the licensed online pharmacy, RxPulsar.com. With over 30 years of practice...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “ENCORAT™ CHRONO prolonged-release tablets 300mg, 30pcs”

Your email address will not be published. Required fields are marked

Similar products

CONVALIS™ capsules 300mg, 100pcs

$72.00
Add to cart

CONVALIS™ capsules 300mg, 50pcs

$39.00
Add to cart

CONVULEX™ IV solution 100mg/ml (5ml), 5 ampoules

$67.00
Add to cart

KEPPRA™ tablets 500mg, 60pcs

$122.00
Add to cart

KEPPRA™ concentrate for infusion solution 100mg/ml (5ml), 10 vials

$292.00
Add to cart

KEPPRA™ tablets 250mg, 30pcs

$32.00
Add to cart

KATENA™ capsules 400mg, 100pcs

$107.00
Add to cart

KATENA™ capsules 400mg, 50pcs

$65.00
Add to cart

CARBAMAZEPINE-ALSI™ tablets 200mg, 40pcs

$10.00
Add to cart

CARBAMAZEPINE VELFARM™ tablets 200mg, 50pcs

$10.00
Add to cart

INFIRA™ tablets 500mg, 100pcs

$2,120.00
Add to cart

INFIRA™ granules for oral solution 500mg, 56pcs

$1,932.00
Add to cart

ZONEGRAN™ capsules 50mg, 28pcs

$121.00
Add to cart

ZONEGRAN™ capsules 100mg, 56pcs

$339.00
Add to cart

ZONEGRAN™ capsules 25mg, 14pcs

$43.00
Add to cart

DEPAKINE™ syrup 57.64mg/ml (150ml)

$29.00
Add to cart

DEPAKINE™ CHRONO prolonged-release tablets 300mg, 100pcs

$30.00
Add to cart

DEPAKINE™ CHRONOSPHERE prolonged-release granules 100mg, sachets 30pcs

$8.00
Add to cart

DEPAKINE™ CHRONOSPHERE prolonged-release granules 500mg, 30 sachets

$36.00
Add to cart

DEPAKINE™ ENTERIC 300 enteric tablets 300mg, 100pcs

$29.00
Add to cart

GABAGAMMA™ capsules 300mg, 50pcs

$57.00
Add to cart

GABAPENTIN™-SZ™ capsules 300mg, 50pcs

$34.00
Add to cart

VIMPAT™ tablets 200mg, 56pcs

$262.00
Add to cart

VALPARIN™ XR prolonged-release tablets 500mg, 100pcs

$43.00
Add to cart
Select your currency